Accuray Buys TomoTherapy To Create 'Premier' Radiation Oncology Company
This article was originally published in The Gray Sheet
Radiosurgery device maker Accuray is acquiring radiation therapy developer TomoTherapy for $277 million in cash and stock to form “the premier radiation oncology company,” according to the firms.
You may also be interested in...
Encision CEO Fred Perner dead at 59. Solta Medical CEO resigns. Chembio president and CEO announces he will retire in May. FDA gains permanent regulatory affairs chief. More people news.
Accuray, Svelte Medical Systems and Sonoma Orthopedics get new CEOs, and more personnel news from device companies.
St. Jude Medical’s Ilumien